JP2024511478A5 - - Google Patents
Info
- Publication number
- JP2024511478A5 JP2024511478A5 JP2023559013A JP2023559013A JP2024511478A5 JP 2024511478 A5 JP2024511478 A5 JP 2024511478A5 JP 2023559013 A JP2023559013 A JP 2023559013A JP 2023559013 A JP2023559013 A JP 2023559013A JP 2024511478 A5 JP2024511478 A5 JP 2024511478A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- amino acid
- acid sequence
- domain containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166805P | 2021-03-26 | 2021-03-26 | |
| US63/166,805 | 2021-03-26 | ||
| PCT/US2022/022035 WO2022204565A1 (en) | 2021-03-26 | 2022-03-25 | Combinations comprising anti-tm4sf1 antibodies and immunotherapeutic agents and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511478A JP2024511478A (ja) | 2024-03-13 |
| JP2024511478A5 true JP2024511478A5 (enExample) | 2025-04-01 |
Family
ID=83397945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559013A Pending JP2024511478A (ja) | 2021-03-26 | 2022-03-25 | 抗ｔｍ４ｓｆ１抗体および免疫療法剤を含む組合せ剤ならびにそれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240166759A1 (enExample) |
| EP (1) | EP4313144A4 (enExample) |
| JP (1) | JP2024511478A (enExample) |
| CN (1) | CN117355333A (enExample) |
| AU (1) | AU2022242927A1 (enExample) |
| CA (1) | CA3213164A1 (enExample) |
| WO (1) | WO2022204565A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX384984B (es) * | 2013-10-10 | 2025-03-14 | Beth Israel Deaconess Medical Ct Inc | Proteinas de union del miembro 1 de la familia de transmembrana 4 l-seis (tm4sf1) y metodos de uso de las mismas. |
| TW201902514A (zh) * | 2017-06-05 | 2019-01-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | Ｐｄ－１抗體與ｖｅｇｆ配體或ｖｅｇｆ受體抑制劑聯合在製備治療腫瘤的藥物中的用途 |
| MX2020002241A (es) * | 2017-08-28 | 2020-09-03 | Angiex Inc | Anticuerpos anti-tm4sf y métodos de uso de los mismos. |
| EP3765516A2 (en) * | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules and uses thereof |
| MX2021010254A (es) * | 2019-02-27 | 2021-09-21 | Angiex Inc | Conjugados de anticuerpo-farmaco que comprenden anticuerpos anti-tm4sf1 y metodos de uso de los mismos. |
-
2022
- 2022-03-25 JP JP2023559013A patent/JP2024511478A/ja active Pending
- 2022-03-25 CA CA3213164A patent/CA3213164A1/en active Pending
- 2022-03-25 AU AU2022242927A patent/AU2022242927A1/en active Pending
- 2022-03-25 EP EP22776760.5A patent/EP4313144A4/en active Pending
- 2022-03-25 WO PCT/US2022/022035 patent/WO2022204565A1/en not_active Ceased
- 2022-03-25 CN CN202280037096.1A patent/CN117355333A/zh active Pending
-
2023
- 2023-09-25 US US18/473,511 patent/US20240166759A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI851633B (zh) | 人源化抗人類-pd-1抗體 | |
| US20230322920A1 (en) | Multi-specific antibodies and methods of making and using thereof | |
| TWI664980B (zh) | 抗-α4β7抗體之用途 | |
| JP7757347B2 (ja) | 操作された抗ｉｌ－２抗体 | |
| US20210147543A1 (en) | Immunotherapy for hepatocellular carcinoma | |
| CN108473578A (zh) | 治疗癌症的抗pd-1抗体和双特异性抗cd20/抗cd3抗体组合 | |
| JP2019530434A5 (enExample) | ||
| TW201609141A (zh) | 活化人類ｃｄ４０之抗體及抗人類ｐｄ－ｌ１之抗體之組合療法 | |
| CA3084495A1 (en) | Humanized anti-liv1 antibodies for the treatment of breast cancer | |
| JP2023512454A (ja) | タンパク質治療のための製剤 | |
| CN117241832A (zh) | B淋巴细胞特异性的鹅膏毒素抗体缀合物 | |
| US20230257474A1 (en) | Uveal melanoma treatment using sea-cd40 | |
| KR20230023650A (ko) | 항-cd30 항체-약물 컨쥬게이트의 조합을 사용하여 암을 치료하는 방법 | |
| TW202207991A (zh) | 用於單獨或組合使用ｂ７－ｈ３抗體－藥物綴合物的方法 | |
| TW202206100A (zh) | 癌症之治療 | |
| JP2024511478A5 (enExample) | ||
| WO2025149947A1 (en) | Antibody-drug conjugates | |
| JP2025514847A (ja) | Ｆａｓ軸拮抗薬及びＴｒｅｇ細胞枯渇剤拮抗薬を含む癌の治療のための併用療法 | |
| WO2023213814A1 (en) | New formulation of anti vista antibody | |
| WO2022057910A1 (en) | Combination therapies targeting c5ar and pd-1/pd-l1 pathways | |
| TW201902462A (zh) | 用於免疫促效劑之新穎投與途徑 | |
| WO2025076389A1 (en) | Methods of treating advanced solid tumors with b7-h4 antibody-drug conjugates | |
| CA3066518C (en) | Immunotherapy for hepatocellular carcinoma | |
| KR20250155046A (ko) | 다작용성 항체 | |
| RU2024105343A (ru) | Белок, специфически связывающийся с pd-1, и его фармацевтическое применение |